Literature DB >> 35918551

Duodenal switch without versus with laparoscopic cholecystectomy: a perioperative risk comparative analysis of the MBSAQIP database (2015-2019).

Ben Clapp1, Michal Janik2, John Corbett1, Ahmet Vahibe3, Omer Ul Hassan3, Farah Husain4, Rana Pullat5, Omar M Ghanem6.   

Abstract

BACKGROUND: The results of concurrent cholecystectomy with Roux-en Y gastric bypass and sleeve gastrectomy have been well elucidated. Large-scale data on the outcomes of concomitant cholecystectomy during biliopancreatic diversion with duodenal switch (BPD-DS) are still lacking. Our study aimed to explore whether simultaneous cholecystectomy with BPD-DS alters the 30-day postoperative outcomes.
METHODS: We conducted a retrospective analysis of the MBSAQIP database between 2015 and 2019. Propensity-score matching (PSM) in BPD-DS with cholecystectomy (Group 1) and BPD-DS without cholecystectomy (Group 2) cohorts was performed (PSM ratio 1:2). The two groups were matched for a total of 21 baseline variables including age, gender, BMI, ASA class, and other medical comorbidities and conditions. The 30-day postoperative morbidity, mortality, reoperation, reintervention, and readmissions were obtained.
RESULTS: Initially, 568 patients in Group 1 and 5079 in Group 2 were identified. After performing PSM, 564 and 1128 patients respectively were compared. The BPD-DS with cholecystectomy group reported a higher rate of reoperation and reintervention compared to BPD-DS alone (3.9% versus 2.4% and 3.2% versus 2%, respectively), even though it did not reach statistical significance. The intervention time was significantly higher in Group 1 compared to Group 2 (192.4 ± 77.6 versus 126.4 ± 61.4 min). Clavien-Dindo complications (1-5) were similar between these two PSM cohorts.
CONCLUSION: Concomitant cholecystectomy during BPD-DS increases operative times but does not affect the other outcomes. Based on our results, the decision of cholecystectomy at the time of BPD-DS should be left to the surgeon's judgment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cholecystectomy; Clavien-Dindo complications; Duodenal switch; Operative time; Reintervention; Reoperation

Year:  2022        PMID: 35918551     DOI: 10.1007/s00464-022-09477-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  13 in total

1.  Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Laura Leccesi; Giuseppe Nanni; Alfons Pomp; Marco Castagneto; Giovanni Ghirlanda; Francesco Rubino
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

2.  Cholecystectomy in Patients Submitted to Bariatric Procedure: A Systematic Review and Meta-analysis.

Authors:  Francisco Tustumi; Wanderley M Bernardo; Marco A Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

3.  Reluctance in duodenal switch adoption: an international survey among bariatric surgeons.

Authors:  Benjamin Clapp; Joseph N Badaoui; Jesus A Gamez; Andres Vivar; Omar M Ghanem
Journal:  Surg Obes Relat Dis       Date:  2021-07-06       Impact factor: 4.734

4.  Two years of clinical experience with biliopancreatic bypass for obesity.

Authors:  N Scopinaro; E Gianetta; D Civalleri; U Bonalumi; V Bachi
Journal:  Am J Clin Nutr       Date:  1980-02       Impact factor: 7.045

5.  Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients.

Authors:  Philippe Topart; Guillaume Becouarn; Patrick Ritz
Journal:  Surg Obes Relat Dis       Date:  2012-03-03       Impact factor: 4.734

6.  Gallbladder management in obesity surgery.

Authors:  Edward E Mason; Kathleen E Renquist
Journal:  Obes Surg       Date:  2002-04       Impact factor: 4.129

7.  Ten year comparative analysis of sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch in patients with BMI ≥ 50 kg/m2.

Authors:  Justin Maroun; Mark Li; Omobolanle Oyefule; Joseph El Badaoui; Travis McKenzie; Michael Kendrick; Todd Kellogg; Omar M Ghanem
Journal:  Surg Endosc       Date:  2021-11-03       Impact factor: 3.453

8.  Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary.

Authors:  Sergio Jose Bardaro; Michel Gagner; Esther Consten; William Barry Inabnet; Daniel Herron; Gregory Dakin; Alfons Pomp
Journal:  Surg Obes Relat Dis       Date:  2007 Sep-Oct       Impact factor: 4.734

9.  Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery.

Authors:  Adolfo Leyva-Alvizo; Gabriela Arredondo-Saldaña; Valeria Leal-Isla-Flores; John Romanelli; Ranjan Sudan; Karen E Gibbs; Anthony Petrick; Ian S Soriano
Journal:  Surg Obes Relat Dis       Date:  2019-10-31       Impact factor: 4.734

10.  Biliopancreatic diversion with a duodenal switch.

Authors:  D S Hess; D W Hess
Journal:  Obes Surg       Date:  1998-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.